Author/Authors :
Meyer Elbaz، نويسنده , , Elyes El Mokhtar، نويسنده , , Khalife Khalife، نويسنده , , Bernard Citron، نويسنده , , Karl Izaaz، نويسنده , , Martial Hamon، نويسنده , , Jean-Michel Juliard MD، نويسنده , , Florence Leclercq، نويسنده , , Joelle Fourcade، نويسنده , , Janus Lipiecki، نويسنده , , Rémi Sabatier، نويسنده , , Vincent Boulet، نويسنده , , Jean-Pierre Rinaldi، نويسنده , , Sami Mourali، نويسنده , , Michel Fatouch، نويسنده , , Alain Asmar، نويسنده , , Pierre Gabriel Steg، نويسنده , , Jacques Puel، نويسنده , , Didier Carrie، نويسنده , , BET Study Group، نويسنده ,
Abstract :
Background Preliminary trials of direct coronary stenting have demonstrated the benefits of this approach. It lowers procedural cost, time, and radiation exposure compared with predilatation. Nevertheless, the long-term outcome after direct stenting remains less well known. Methods Between January and September 1999, 338 patients were randomly assigned to either direct stent implantation (DS+, N = 173) or standard stent implantation with balloon predilatation (DS−, N = 165). Clinical follow-up was performed. Results Baseline characteristics were similar in the 2 groups. Procedural success was achieved in 98.3% of patients assigned to DS+ and 97.5% of patients assigned to DS− (not significant). Clinical follow-up was obtained in 99% of patients (mean 16.4 ± 4.6 months). Major adverse cardiac events—defined as whichever of the following occurred first; cardiac death, myocardial infarction, unstable angina, new revascularization—were observed at a higher rate in the DS+ group than in the DS−, but this difference was not significant (11.3% vs 18.2%, P = not significant). The difference in target lesion revascularization rate in the DS+ group (7%) and DS− group (5.2%) was also not significant. Multivariate analysis showed that direct stenting had no influence on long-term major adverse cardiac events rate. Independent relationships were found between long-term major adverse cardiac events rate and final minimal lumen diameter <2.48 mm (relative risk [RR] 0.449, CI 0.239-0.845, P = .013), prior myocardial infarction (RR 2.028, CI 1.114-3.69, P = .02), and hypertension (RR 1.859, CI 1.022-3.383, P = .042). Conclusion The main finding that emerges from this randomized study is that the influence of direct stenting on long-term need for new target lesion revascularization does not differ from that of stenting with balloon predilatation. (Am Heart J 2002;144:e7.)
